BIOMAT Database Logo BIOMAT Database Logo

Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination. 1994

C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Laboratoire de Recherche Chirurgicale, Faculté de Médecine Cochin-Hôpital Cochin, Paris, France.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
February 1995, Transplantation proceedings,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Ex vivo lung model of pig-to-human hyperacute xenograft rejection.
September 1997, The Journal of thoracic and cardiovascular surgery,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
January 1986, The Journal of heart transplantation,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Hyperacute xenograft rejection in the guinea pig to rat heart transplantation model.
June 1990, Transplantation proceedings,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
June 1994, Transplantation proceedings,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
June 1990, Transplantation proceedings,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
The pathogenesis of hyperacute xenograft rejection.
October 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Prevention of hyperacute xenograft rejection by polyclonal antibodies against donor blood cells.
April 1996, Transplantation proceedings,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin.
September 1996, Transplantation,
C Gautreau, and J Cardoso, and G Woimant, and Z Zhao, and C Chereau, and B Cherruau, and N Vandeginste, and P Devillier, and D Houssin
Hyperacute xenograft rejection is not consistent after pig to primate solid organ transplantation.
February 2001, Transplantation,
Copied contents to your clipboard!